Chemical Denervation to Relieve Symptoms in Jugular Venous Compression Syndrome: A Case Report.

Case Reports in Vascular Medicine Pub Date : 2025-02-17 eCollection Date: 2025-01-01 DOI:10.1155/crvm/9186091
Wesley Paulson, Morgan A Voulo, Shivani Patel, Andrew J Rothka, Sarahrose Jonik, Neyha Cherin
{"title":"Chemical Denervation to Relieve Symptoms in Jugular Venous Compression Syndrome: A Case Report.","authors":"Wesley Paulson, Morgan A Voulo, Shivani Patel, Andrew J Rothka, Sarahrose Jonik, Neyha Cherin","doi":"10.1155/crvm/9186091","DOIUrl":null,"url":null,"abstract":"<p><p>Jugular venous compression syndrome (JVCS) is caused by internal jugular vein compression, leading to headaches, neck discomfort, tinnitus, vertigo, confusion, and blurred vision. These impairments can diminish functional outcomes and compromise quality of life for patients. Literature-based treatments focus on surgical approaches and do not include chemodenervation. However, chemodenervation may be an additional treatment modality to consider. We present the first published case of chemodenervation utilized to successfully treat debilitating neck pain, headaches, and vertigo symptoms for JVCS, resulting in improved functionality and quality of life. This chemical denervation to the anterior neck musculature was trialed in hopes of avoiding surgical intervention. After three treatments, significant symptomatic relief with improved ability to work, improved performance of activities of daily living, and enhanced quality of life were noted. Educating physicians about JVCS and the various treatment modalities available is essential, as less invasive treatment options may not only become available to assist with the functional component of the condition but could also serve as potential alternatives to surgical and endovascular management in carefully selected patients, with the goal of optimizing function and improving quality of life among patients.</p>","PeriodicalId":9632,"journal":{"name":"Case Reports in Vascular Medicine","volume":"2025 ","pages":"9186091"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11850062/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Vascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/crvm/9186091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Jugular venous compression syndrome (JVCS) is caused by internal jugular vein compression, leading to headaches, neck discomfort, tinnitus, vertigo, confusion, and blurred vision. These impairments can diminish functional outcomes and compromise quality of life for patients. Literature-based treatments focus on surgical approaches and do not include chemodenervation. However, chemodenervation may be an additional treatment modality to consider. We present the first published case of chemodenervation utilized to successfully treat debilitating neck pain, headaches, and vertigo symptoms for JVCS, resulting in improved functionality and quality of life. This chemical denervation to the anterior neck musculature was trialed in hopes of avoiding surgical intervention. After three treatments, significant symptomatic relief with improved ability to work, improved performance of activities of daily living, and enhanced quality of life were noted. Educating physicians about JVCS and the various treatment modalities available is essential, as less invasive treatment options may not only become available to assist with the functional component of the condition but could also serve as potential alternatives to surgical and endovascular management in carefully selected patients, with the goal of optimizing function and improving quality of life among patients.

化学去神经治疗颈静脉压迫综合征1例报告。
颈静脉压迫综合征(JVCS)是由颈内静脉压迫引起的,导致头痛、颈部不适、耳鸣、眩晕、精神错乱和视力模糊。这些损伤会降低患者的功能结果,降低患者的生活质量。基于文献的治疗侧重于手术方法,不包括化学神经支配。然而,化学神经支配可能是一种额外的治疗方式。我们报告了首次发表的化学神经支配成功治疗JVCS的衰弱性颈部疼痛、头痛和眩晕症状的病例,从而改善了功能和生活质量。对前颈部肌肉组织的化学去神经支配进行了试验,希望能避免手术干预。三次治疗后,症状明显缓解,工作能力改善,日常生活活动能力改善,生活质量提高。教育医生关于JVCS和各种可用的治疗方式是必不可少的,因为较少侵入性的治疗选择不仅可以帮助治疗疾病的功能成分,而且可以作为手术和血管内治疗的潜在替代方案,以优化患者的功能和提高患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
21
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信